
|Videos|June 6, 2017
Jennifer Wenzel on Prioritizing Representation in Clinical Trials
Author(s)Jennifer Wenzel, PhD, RN, CCM, FAAN
Jennifer Wenzel, PhD, RN, CCM, FAAN, discusses why representation in clinical trials is not successful as an afterthought.
Advertisement
Jennifer Wenzel, PhD, RN, CCM, FAAN, of Johns Hopkins University School of Medicine, discusses why representation in clinical trials is not successful as an afterthought.
As funding for research gets tighter, there are less programs to ensure diversity in research — these are often the first programs to be cut when money is short. In response, nurses can advocate for funding and policies which allow for research promoting diversity. The only way to be sure that clinical trials have adequate representation is to make it a priority within research planning.
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
FDA Approves Oral Nilotinib Tablets for Ph+ CML
3
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
4
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
5































































